ACSL4 and hepatocellular carcinoma: Moreover, ACSL4 could upregulate the master lipogenesis regulator sterol regulatory element binding protein 1 (SREBP1) (Chen et al., 2021) and stabilize the oncoprotein c-Myc, resulting in HCC prognosis (Chen et al., 2020).